# Icosapent Ethyl

NDC: 0054-0621
Generic name: Icosapent Ethyl
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20201104

FDA application: ANDA209457

## Active ingredients

- ICOSAPENT ETHYL: .5 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0621"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0621
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e3d38d1d-fbe7-413d-849a-675e7dfa9b0a